Niraparib eller et farmasøytisk akseptabelt salt, stereoisomer eller tautomer derav, spesielt tosylatet eller et hydrat, spesielt tosylatmonohydratet

• 收藏
• 分享

专利权人:

MSD Italia S.R.L.

发明人:

申请号：

NO2018016

公开号：

NO2018016I2

申请日:

2018.05.14

申请国别(地区):

NO

年份:

2018

代理人:

摘要：

The present invention relates to combinations of compounds of formula I: and other anti-cancer agents which are useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage and skin senescence and UV-induced skin damage.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/